Adherium Ltd
Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, a system for management of chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease. It also provides … Read more
Adherium Ltd (ADR) - Net Assets
Latest net assets as of December 2025: AU$-787.24K AUD
Based on the latest financial reports, Adherium Ltd (ADR) has net assets worth AU$-787.24K AUD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$4.16 Million) and total liabilities (AU$4.94 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$-787.24K |
| % of Total Assets | -18.94% |
| Annual Growth Rate | N/A |
| 5-Year Change | -133.94% |
| 10-Year Change | -117.35% |
| Growth Volatility | 986.0 |
Adherium Ltd - Net Assets Trend (2012–2025)
This chart illustrates how Adherium Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Adherium Ltd (2012–2025)
The table below shows the annual net assets of Adherium Ltd from 2012 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | AU$-4.76 Million | -173.50% |
| 2024-06-30 | AU$6.48 Million | -29.67% |
| 2023-06-30 | AU$9.21 Million | +66.41% |
| 2022-06-30 | AU$5.54 Million | -60.55% |
| 2021-06-30 | AU$14.04 Million | +314.75% |
| 2020-06-30 | AU$3.38 Million | +307.71% |
| 2019-06-30 | AU$830.00K | -93.52% |
| 2018-06-30 | AU$12.81 Million | -43.58% |
| 2017-06-30 | AU$22.70 Million | -17.31% |
| 2016-06-30 | AU$27.46 Million | -20.48% |
| 2015-06-30 | AU$34.53 Million | +1494.19% |
| 2014-06-30 | AU$2.17 Million | -6.40% |
| 2014-03-31 | AU$2.31 Million | -33.97% |
| 2013-06-30 | AU$3.50 Million | +3628.18% |
| 2012-06-30 | AU$94.00K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Adherium Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 11619020500.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$132.13 Million | % |
| Other Comprehensive Income | AU$-20.71 Million | % |
| Total Equity | AU$-4.76 Million | 100.00% |
Adherium Ltd Competitors by Market Cap
The table below lists competitors of Adherium Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ZINC of Ireland NL
AU:ZMI
|
$2.37 Million |
|
Blackwall Ltd
AU:BWF
|
$2.37 Million |
|
Tianrong Internet Products and Services Inc
PINK:TIPS
|
$2.37 Million |
|
Sadot Group Inc.
NASDAQ:SDOT
|
$2.37 Million |
|
OFAL
NASDAQ:OFAL
|
$2.37 Million |
|
Hoops Scouting USA
PINK:HSCT
|
$2.37 Million |
|
Doppler S.A.
AT:DOPPLER
|
$2.36 Million |
|
Prime Meridian Resources Corp
PINK:PMDRF
|
$2.36 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Adherium Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 6,480,396 to -4,763,251, a change of -11,243,647 (-173.5%).
- Net loss of 12,679,349 reduced equity.
- Other comprehensive income increased equity by 304,134.
- Other factors increased equity by 1,131,568.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-12.68 Million | -266.19% |
| Other Comprehensive Income | AU$304.13K | +6.39% |
| Other Changes | AU$1.13 Million | +23.76% |
| Total Change | AU$- | -173.50% |
Book Value vs Market Value Analysis
This analysis compares Adherium Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-06-30 | AU$0.83 | AU$0.00 | x |
| 2014-06-30 | AU$0.50 | AU$0.00 | x |
| 2015-06-30 | AU$0.33 | AU$0.00 | x |
| 2016-06-30 | AU$3.29 | AU$0.00 | x |
| 2017-06-30 | AU$0.13 | AU$0.00 | x |
| 2018-06-30 | AU$1.11 | AU$0.00 | x |
| 2019-06-30 | AU$0.07 | AU$0.00 | x |
| 2020-06-30 | AU$0.16 | AU$0.00 | x |
| 2021-06-30 | AU$0.23 | AU$0.00 | x |
| 2022-06-30 | AU$0.04 | AU$0.00 | x |
| 2023-06-30 | AU$0.03 | AU$0.00 | x |
| 2024-06-30 | AU$0.02 | AU$0.00 | x |
| 2025-06-30 | AU$-0.01 | AU$0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Adherium Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1551.49%
- • Asset Turnover: 0.23x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-191.05%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | -3.95% | -24.75% | 0.15x | 1.04x | AU$-488.95K |
| 2014 | -101.90% | -458.74% | 0.17x | 1.29x | AU$-2.59 Million |
| 2014 | -101.89% | -458.88% | 0.17x | 1.29x | AU$-2.42 Million |
| 2015 | -3.63% | -43.17% | 0.08x | 1.08x | AU$-4.71 Million |
| 2016 | -22.97% | -300.27% | 0.07x | 1.05x | AU$-9.05 Million |
| 2017 | -56.42% | -545.80% | 0.09x | 1.11x | AU$-15.08 Million |
| 2018 | -72.90% | -159.16% | 0.38x | 1.20x | AU$-10.62 Million |
| 2019 | -1420.96% | -424.40% | 1.24x | 2.70x | AU$-11.88 Million |
| 2020 | -336.79% | -513.84% | 0.33x | 1.99x | AU$-11.74 Million |
| 2021 | -107.13% | -3749.63% | 0.02x | 1.21x | AU$-16.44 Million |
| 2022 | -181.40% | -1898.68% | 0.06x | 1.54x | AU$-10.60 Million |
| 2023 | -106.99% | -308.54% | 0.25x | 1.38x | AU$-10.78 Million |
| 2024 | -157.77% | -1215.74% | 0.09x | 1.53x | AU$-10.87 Million |
| 2025 | 0.00% | -1551.49% | 0.23x | 0.00x | AU$-12.20 Million |
Industry Comparison
This section compares Adherium Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $12,553,427
- Average return on equity (ROE) among peers: -349.81%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Adherium Ltd (ADR) | AU$-787.24K | -3.95% | N/A | $2.37 Million |
| 4DMEDICAL Ltd (4DX) | $926.64K | -85.93% | 0.18x | $1.03 Billion |
| Aroa Biosurgery Ltd (ARX) | $-22.65 Million | 0.00% | 0.00x | $92.74 Million |
| Atomo Diagnostics Ltd (AT1) | $34.48 Million | -26.73% | 0.05x | $8.96 Million |
| Control Bionics Ltd (CBL) | $6.09 Million | -15.97% | 0.04x | $4.98 Million |
| Cardiex Ltd (CDX) | $3.03 Million | -101.61% | 0.73x | $4.25 Million |
| Compumedics Ltd (CMP) | $9.21 Million | -30.70% | 1.16x | $13.08 Million |
| Cochlear Ltd (COH) | $75.42 Million | 53.19% | 1.13x | $7.01 Billion |
| Cleo Diagnostics Ltd (COV) | $5.83 Million | -68.54% | 0.19x | $23.47 Million |
| Conneqt Health Limited (CQT) | $633.50K | -2871.98% | 13.72x | $4.66 Million |